F02.C4
Dementia in other diseases classified elsewhere, severe, with anxiety
Clinical Classification Guidelines
Inclusion Terms
- Major neurocognitive disorder in other diseases classified elsewhere, severe, with anxiety
Medical Intelligence & Overview
Severe dementia in other diseases classified elsewhere, with anxiety, is a complex neurological condition that impacts cognitive functioning and emotional well-being. This diagnosis indicates significant decline in mental abilities accompanied by clinical levels of anxiety. It is important to recognize the features of this condition to better appreciate its effect on individuals and their caregivers.
Causes & Symptoms
Clinical Causes: Underlying neurological disorders such as Parkinson’s disease, Huntington’s disease, or multiple sclerosis Other serious health conditions that affect the brain, including infections or vascular problems Progression of primary neurodegenerative diseases like Alzheimer’s disease when complications or additional neurological factors are involved Brain injuries or sustained trauma that aggravate existing neurological conditions Advanced stages of systemic illnesses that impact brain function
Key Symptoms: Marked decline in cognitive skills such as memory, reasoning, and problem-solving Severe confusion or disorientation Difficulty communicating or understanding speech Impaired judgment and decision-making capabilities Personality and behavioral changes including agitation or aggression Emotional disturbances like persistent anxiety, fear, or panic Physical symptoms such as tremors, difficulty walking, or muscle weakness linked to the underlying disease Symptoms often worsen over time, affecting overall daily functioning
Diagnostic & Treatment
Diagnosis Path: Diagnosing severe dementia with anxiety involves a comprehensive assessment that includes reviewing medical history, conducting neurological examinations, and performing cognitive tests. Healthcare providers may utilize brain imaging studies such as MRI or CT scans to detect structural changes or lesions. Psychiatric assessments can help identify anxiety symptoms, and screening tools are often used to evaluate the severity of cognitive decline. It is crucial to determine the underlying disease to tailor appropriate management strategies.
Treatment Protocols: Medications to address anxiety, such as certain antidepressants or anti-anxiety drugs, under medical supervision Cholinesterase inhibitors or other drugs targeting cognitive symptoms specific to the underlying disease Behavioral therapies aimed at reducing agitation and managing behavioral disturbances Environmental modifications to create a safe and calming setting Support for caregivers through education and counseling Engagement in activities that promote mental stimulation and emotional expression Addressing comorbid conditions that may affect neurological health
Clinical Advice & FAQs
Billing Guidance
Is F02.C4 a billable ICD-10 code?
Yes, F02.C4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F02.C4?
Clinical documentation must specify the nature of Dementia in other diseases classified elsewhere, severe, with anxiety and any associated comorbidities for accurate reporting.
Cite this Clinical Reference